Employers are projecting a median 10% increase in healthcare costs for 2026, driven largely by high claims and specialty drug expenses, according to a recent survey. The post Why Employers Predict a 10% Increase in Healthcare Costs for 2026 appeared first on MedCity News.
As measles surged in Texas early this year, the Trump administration’s actions sowed fear and confusion among CDC scientists that kept them from performing the agency’s most critical function — emergency response — when it mattered most, an investigation from KFF Health News shows. The outbreak soon became the worst the United States has endured…
KFF Health News editor-at-large for public health Céline Gounder discussed bird flu on CBS’ “CBS Mornings Plus” on March 20. Gounder discussed funding cuts at Johns Hopkins University and other research institutions on CBS News’ “CBS Morning News” on March 17. She also discussed the Centers for Disease Control and Prevention’s airplane wastewater testing to…
Dexcom recently became the first medical device company to embed generative AI into a continuous glucose monitor. Adding generative AI to the company’s Stelo glucose monitor will give users more personalized recommendations about how to improve their metabolic health, said Dexcom COO Jake Leach. The post Dexcom Adds Generative AI Platform to Its Over-the-Counter CGM…
House Republicans introduced a proposal seeking to cut Medicaid spending by hundreds of billions of dollars. Healthcare leaders are slamming the budget plan, highlighting that it would result in millions of people losing coverage, as well as a surge in uncompensated care for providers. The post GOP Seeks to Drastically Cut Medicaid Spending — How…
Neopharmed Gentili is acquiring European rights to Orladeyo, bringing the Italy-based pharmaceutical company into rare disease. BioCryst’s Orladeyo is approved for treating patients with the rare disease hereditary angioedema. The post BioCryst Pharma Sells European Business for Rare Disease Drug in $250M Deal appeared first on MedCity News.
Dr. Monarez is the agency’s current acting director
MIAMI — When leaders of Florida’s most populous county met in September to pick a site for what could become the nation’s largest trash incinerator, so many people went to the government center to protest that overflow seating spilled into the building’s atrium. “MIRAMAR SAYS NO TO INCINERATOR! NOT IN OUR BACKYARD,” read green T-shirts…
That is the title of a KFF article published last week. The results are based on KFF’s 2024 Employer Health Benefits Survey. They write: For KFF’s survey of 2,142 randomly selected companies, officials from those with 500 or more employees were asked how much of the rebates negotiated by [pharmacy benefit managers] PBMs returned to…
Not really. At least according a study by Wilson et al. 2025 in Science. In 11 studies, we found that participants typically did not enjoy spending 6 to 15 minutes in a room by themselves with nothing to do but think, that they enjoyed doing mundane external activities much more, and that many preferred to…